| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase II study of oral clofazimine in unresectable and metastatic hepatocellular carcinoma
|
Ruff, P.
|
|
|
9 |
2 |
p. 217-219
|
artikel
|
| 2 |
A phase II study of oral clofazimine in unresectable and metastatichepatocellular carcinoma
|
P. Ruff
|
|
1998
|
9 |
2 |
p. 217-219
3 p.
|
artikel
|
| 3 |
A rise in our impact factor
|
|
|
|
9 |
2 |
p. 123
|
artikel
|
| 4 |
A rise in our impact factor; UK needs more cancer specialists; Freemovement of patients soon reality in the EU?; Kyoto: Only a small step;Notwithstanding motor racing, Europe agrees to ban tobacco advertising; Cancerco-op; Economics and cancer; Italian furor over Di Bella; Awards,appointments; Cooperation sought for gastric-MALT-lymphoma trial; Perhaps noteveryone knows that...
|
|
|
1998
|
9 |
2 |
p. 123-128
6 p.
|
artikel
|
| 5 |
Autologous peripheral blood progenitor cell transplantation mobilized with high-dose cytarabine in acute myeloid leukemia in first complete remission
|
Pavlovsky, S.
|
|
|
9 |
2 |
p. 151-157
|
artikel
|
| 6 |
Autologous peripheral blood progenitor cell transplantation mobilizedwith high-dose cytarabine in acute myeloid leukemia in first completeremission
|
S. Pavlovsky
|
|
1998
|
9 |
2 |
p. 151-157
7 p.
|
artikel
|
| 7 |
Awards, appointments
|
|
|
|
9 |
2 |
p. 126-127
|
artikel
|
| 8 |
Book review
|
Costa, A.
|
|
|
9 |
2 |
p. 228
|
artikel
|
| 9 |
Book review
|
Krauseneck, P.
|
|
|
9 |
2 |
p. 232
|
artikel
|
| 10 |
Cancer co-op
|
|
|
|
9 |
2 |
p. 124-125
|
artikel
|
| 11 |
Consolidation therapy for advanced ovarian cancer
|
Lambert, H.E.
|
|
|
9 |
2 |
p. 229
|
artikel
|
| 12 |
Consolidation therapy for advanced ovarian cancer
|
van der Burg, M.E.L.
|
|
|
9 |
2 |
p. 229-230
|
artikel
|
| 13 |
Consolidation therapy for advanced ovarian cancer
|
H. E. Lambert
|
|
1998
|
9 |
2 |
p. 229-229
1 p.
|
artikel
|
| 14 |
Consolidation therapy for advanced ovarian cancer: Response
|
M.E.L. van der Burg
|
|
1998
|
9 |
2 |
p. 229-230
2 p.
|
artikel
|
| 15 |
Contents of the next issue
|
|
|
|
9 |
2 |
p. v
|
artikel
|
| 16 |
Cooperation sought for gastric-MALT-lymphoma trial
|
|
|
|
9 |
2 |
p. 127
|
artikel
|
| 17 |
Copyright
|
|
|
|
9 |
2 |
p. iii
|
artikel
|
| 18 |
Cytosine arabinoside, etoposide and aclarubicin (AVA) for the treatment of acute myeloid leukemia (AML) in elderly patients
|
Staib, P.
|
|
|
9 |
2 |
p. 221-223
|
artikel
|
| 19 |
Cytosine arabinoside, etoposide and aclarubicin (AVA) for the treatmentof acute myeloid leukemia (AML) in elderly patients
|
P. Staib
|
|
1998
|
9 |
2 |
p. 221-223
3 p.
|
artikel
|
| 20 |
Detection of primary breast cancer presenting as metastatic carcinoma ofunknown primary origin by ^111In-pentetreotide scan
|
R. Lenzi
|
|
1998
|
9 |
2 |
p. 213-216
4 p.
|
artikel
|
| 21 |
Detection of primary breast cancer presenting as metastatic carcinoma of unknown primary origin by 111In-pentetreotide scan
|
Lenzi, R.
|
|
|
9 |
2 |
p. 213-216
|
artikel
|
| 22 |
Economics and cancer
|
|
|
|
9 |
2 |
p. 125
|
artikel
|
| 23 |
Editorial board
|
|
|
|
9 |
2 |
p. iv
|
artikel
|
| 24 |
5-Fluorouracil and mitomycin-C in colorectal cancer: Unacceptable conclusion
|
Ross, P.
|
|
|
9 |
2 |
p. 230
|
artikel
|
| 25 |
5-Fluorouracil and mitomycin-C in colorectal cancer: Unacceptable conclusion
|
Herrmann, R.
|
|
|
9 |
2 |
p. 230
|
artikel
|
| 26 |
5-Fluorouracil and mitomycin-C in colorectal cancer: Unacceptableconclusion
|
R. Herrmann
|
|
1998
|
9 |
2 |
p. 230-230
1 p.
|
artikel
|
| 27 |
5-Fluorouracil and mitomycin-C in colorectal cancer: Unacceptableconclusion (Response)
|
P. Ross
|
|
1998
|
9 |
2 |
p. 230-230
1 p.
|
artikel
|
| 28 |
For which patients with aggressive non-Hodgkin’s lymphoma is prophylaxis for central nervous system disease mandatory?
|
Bos, G.M.J.
|
|
|
9 |
2 |
p. 191-194
|
artikel
|
| 29 |
For which patients with aggressive non-Hodgkins lymphoma is prophylaxisfor central nervous system disease mandatory?
|
G. M. J. Bos
|
|
1998
|
9 |
2 |
p. 191-194
4 p.
|
artikel
|
| 30 |
Free movements of patients soon reality in the EU?
|
|
|
|
9 |
2 |
p. 123
|
artikel
|
| 31 |
Hematopoietic stem cell transplantation in chronic lymphocytic leukemia: A report of 12 patients from a single institution
|
Esteve, J.
|
|
|
9 |
2 |
p. 167-172
|
artikel
|
| 32 |
High-dose chemotherapy for chronic lymphocytic leukemia: Eligibility, timing, and benefit?
|
Khouri, I.F.
|
|
|
9 |
2 |
p. 131-132
|
artikel
|
| 33 |
High-dose chemotherapy for chronic lymphocytic leukemia: Eligibility,timing, and benefit?
|
I. F. Khouri
|
|
1998
|
9 |
2 |
p. 131-132
2 p.
|
artikel
|
| 34 |
High-dose topotecan with granulocyte-colony stimulating factor in fluoropyrimidine-refractory colorectal cancer: A phase II and pharmacodynamic study
|
Rowinsky, E.K.
|
|
|
9 |
2 |
p. 173-180
|
artikel
|
| 35 |
High-dose topotecan with granulocyte-colony stimulating factor influoropyrimidine-refractory colorectal cancer: A phase II and pharmacodynamicstudy
|
E. K. Rowinsky
|
|
1998
|
9 |
2 |
p. 173-180
8 p.
|
artikel
|
| 36 |
High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia
|
Karakas, T.
|
|
|
9 |
2 |
p. 159-165
|
artikel
|
| 37 |
High expression of bcl-2 mRNA as a determinant of poor prognosis in acutemyeloid leukemia
|
T. Karakas
|
|
1998
|
9 |
2 |
p. 159-165
7 p.
|
artikel
|
| 38 |
In this Issue
|
|
|
|
9 |
2 |
p. v
|
artikel
|
| 39 |
In This Issue: High-dose topotecan in colorectal cancer; IsCNS-prophylaxis in NHL obsolete?; No role for pneumatic compression in thetreatment of post-mastectomy lymphedema.
|
|
|
1998
|
9 |
2 |
p. 4-4
1 p.
|
artikel
|
| 40 |
Italian furor over Di Bella
|
|
|
|
9 |
2 |
p. 125-126
|
artikel
|
| 41 |
J. B. Posner (ed). Neurologic complications of cancer
|
P. Krauseneck
|
|
1998
|
9 |
2 |
p. 232-232
1 p.
|
artikel
|
| 42 |
Kyoto: Only a small step
|
|
|
|
9 |
2 |
p. 123-124
|
artikel
|
| 43 |
Malignant pleural mesothelioma
|
Baas, P.
|
|
|
9 |
2 |
p. 139-149
|
artikel
|
| 44 |
Malignant pleural mesothelioma
|
P. Baas
|
|
1998
|
9 |
2 |
p. 139-149
11 p.
|
artikel
|
| 45 |
M. S. Wood, E. P. Delozier (eds). Cancer resources on the Internet
|
A. Costa
|
|
1998
|
9 |
2 |
p. 228-228
1 p.
|
artikel
|
| 46 |
Notwithstanding motor racing, Europe agrees to ban tobacco advertising
|
|
|
|
9 |
2 |
p. 124
|
artikel
|
| 47 |
Onycholysis in patients treated with docetaxel
|
Obermair, A.
|
|
|
9 |
2 |
p. 230-231
|
artikel
|
| 48 |
Onycholysis in patients treated with docetaxel
|
A. Obermair
|
|
1998
|
9 |
2 |
p. 230-231
2 p.
|
artikel
|
| 49 |
Perhaps not everyone knows that…
|
|
|
|
9 |
2 |
p. 127-128
|
artikel
|
| 50 |
Positive immunostaining with MLuC1 of bone marrow aspirate predicts poor outcome in patients with small-cell lung cancer
|
Pasini, F.
|
|
|
9 |
2 |
p. 181-185
|
artikel
|
| 51 |
Positive immunostaining with MLuC1 of bone marrow aspirate predicts pooroutcome in patients with small-cell lung cancer
|
F. Pasini
|
|
1998
|
9 |
2 |
p. 181-185
5 p.
|
artikel
|
| 52 |
Quality of life assessment in patients receiving adjuvant therapy forbreast cancer: The IBCSG approach
|
J. Bernhard
|
|
1998
|
9 |
2 |
p. 231-231
1 p.
|
artikel
|
| 53 |
Quality of life assessment in patients receiving adjuvant therapy for breast cancer: The IBCSG approach
|
Bernhard, J.
|
|
|
9 |
2 |
p. 231
|
artikel
|
| 54 |
Table of Contents
|
|
|
|
9 |
2 |
p. ii-iii
|
artikel
|
| 55 |
Ten-year results of a strategy combining three cycles of ABVD and high-dose extended irradiation for treating Hodgkin’s disease at advanced stages
|
Andrieu, J.-M.
|
|
|
9 |
2 |
p. 195-203
|
artikel
|
| 56 |
The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: Growth stimulation in the presence of tamoxifen
|
Boylan, M.
|
|
|
9 |
2 |
p. 205-211
|
artikel
|
| 57 |
The anti-proliferative effect of suramin towards tamoxifen-sensitive andresistant human breast cancer cell lines in relation to expression ofreceptors for epidermal growth factor and insulin-like growth factor-I: Growthstimulation in the presence of tamoxifen
|
M. Boylan
|
|
1998
|
9 |
2 |
p. 205-211
7 p.
|
artikel
|
| 58 |
The changing landscape of breast cancer clinical research
|
Piccart, M.J.
|
|
|
9 |
2 |
p. 133-138
|
artikel
|
| 59 |
The changing landscape of breast cancer clinical research
|
M. J. Piccart
|
|
1998
|
9 |
2 |
p. 133-138
6 p.
|
artikel
|
| 60 |
The role of pneumatic compression in the treatment of postmastectomy lymphedema. A randomized phase III study
|
Dini, D.
|
|
|
9 |
2 |
p. 187-190
|
artikel
|
| 61 |
The role of pneumatic compression in the treatment of postmastectomylymphedema. A randomized phase III study
|
D. Dini
|
|
1998
|
9 |
2 |
p. 187-190
4 p.
|
artikel
|
| 62 |
UK needs more cancer specialists
|
|
|
|
9 |
2 |
p. 123
|
artikel
|
| 63 |
Understanding and overcoming resistance to chemotherapy in acute myeloid leukemia
|
Zittoun, R.
|
|
|
9 |
2 |
p. 129-130
|
artikel
|
| 64 |
Understanding and overcoming resistance to chemotherapy in acute myeloidleukemia
|
R. Zittoun
|
|
1998
|
9 |
2 |
p. 129-130
2 p.
|
artikel
|
| 65 |
Vinorelbine, bleomycin and methotrexate as a salvage therapy for patients with head and neck squamous carcinoma in relapse after cisplatin/fluorouracil
|
Iop, A.
|
|
|
9 |
2 |
p. 225-227
|
artikel
|
| 66 |
Vinorelbine, bleomycin and methotrexate as a salvage therapy for patientswith head and neck squamous carcinoma in relapse aftercisplatin/fluorouracil
|
A. Iop
|
|
1998
|
9 |
2 |
p. 225-227
3 p.
|
artikel
|
Tijdschrift beschrijving